Strategic Information for the Life Science and Analytical Instrument Industry
In a recently published report, Strategic Directions International (SDi), IBO’s publisher, provides an overview of the fast-growing Chinese analytical instrument and lab product market. The report, “China 2021: The Market for Laboratory Analytical & Life Science Instruments,” includes forecast and market segmentation details for ten categories of laboratory technologies (see below). China’s investment in R&D, […]
As one of the fastest growing segments of the biopharma market, cell and gene therapies (CGT) are creating a new era of medical treatments. Making cell and gene therapies possible are genetic manipulation and cell growth and maintenance. To accomplish these tasks in R&D, quality control and manufacturing, scientists are drawing on established laboratory tools […]
A new report from the US Congressional Budget Office (CBO) provides a snapshot of the US pharmaceutical industry and its R&D patterns. The report also explains the important role that the federal government plays in drug development and sales. Here, IBO gives an overview of the data presented in the report on pharmaceutical sales and […]
Testing has been at the forefront of public health efforts and challenges since the beginning of the pandemic caused by SARS-CoV-2, the virus responsible for COVID-19 disease. By April last year, it became increasingly clear that testing would be crucial to public health and safety. However, global testing capacities substantially lagged behind demand as shortages […]
Bioprocessing International (BPI) US West 2021 kicked off its virtual edition this morning, Monday March 29. An annual event, BPI West encompasses presentation, posters and networking events focused on the latest developments in bioprocessing and cell and gene therapy. A talk this morning, “Integration of Paperless Benchtop Instruments in Clinical Manufacturing,” presented by Simon Barskyi […]
In 2020, the laboratory analytical and life science instrumentation industry played a critical role in assisting various end-markets in abating the COVID-19 pandemic. Select vendors were able to weather business disruptions by meeting pandemic-related demand for certain product offerings. However, the question now is, what will be the condition of the laboratory analytical and life […]
The annual BioProcess International US West Conference & Exhibition will be held March 29–30 virtually. The conference consists of six tracks: Cell Line Development & Engineering; Cell Culture; Recovery & Purification; Manufacturing Strategy & Bioprocessing 4.0; Intensified & Continuous Processing; Cell & Gene Therapies; and the 4th Annual BioInnovation Group Technology Session. BioProcess International US […]
The advent of the COVID-19 pandemic in 2020 has made the need for molecular point-of-care (mPOC) technologies, such as testing for strep throat, HPV, tuberculosis and more, have further driven demand from the clinical and medical sectors. As a result, more companies are offering related products to fulfill end-user demand. In January 2021, Kalorama Information […]
It has been a busy beginning of the year for Danaher’s Life Sciences segment. In January, the business reported 2020 revenues of $10.6 billion, representing 47% of the total revenues of science and technology conglomerate Danaher. The Life Sciences unit such as biopharmaceuticals and COVID-19 vaccines. In 2020, the pharmaceutical end-market represented approximately 25% of […]
Early signs from the Biden Administration indicate the Administration is elevating the role of science in its policymaking and actions. President Biden has already promoted the role of science advisor and director of the Office of Science and Technology policy to the level of a Cabinet position. Made up of 25 members, Cabinet members serve […]
